FDA: Size of bio-batch [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2013-12-10 13:05 (2641 d 02:36 ago) – Posting: # 12028
Views: 11,411

Dear all,

for pivotal BE studies EMA requires that

The test product should usually originate from a batch of ≥1/10 of production scale or 100,000 units, whichever is greater, unless otherwise justified.


Do you know of a corresponding requirement by the FDA? In the Summary Table 11 sizes of the bio-batch and production batch have to be reported.

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,362 posts in 4,461 threads, 1,492 registered users;
online 15 (0 registered, 15 guests [including 6 identified bots]).
Forum time: Thursday 15:42 UTC (Europe/Vienna)

Being really good at C++ is like being really good
at using rocks to sharpen sticks.    Thant Tessman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5